The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Mitochondrial DNA damage and atherosclerosis
Open accessAbstract
Mitochondria are often regarded as the cellular powerhouses through their ability to generate ATP, the universal fuel for metabolic processes. However, in recent years mitochondria have been recognised as critical regulators of cell death, inflammation, metabolism, and the generation of reactive oxygen species (ROS). Thus, mitochondrial dysfunction directly promotes cell death, inflammation, and oxidative stress and alters metabolism. These are key processes in atherosclerosis and there is now evidence that mitochondrial DNA (mtDNA) damage leads to mitochondrial dysfunction and promotes atherosclerosis directly. In this review we discuss the recent evidence for and mechanisms linking mtDNA defects and atherosclerosis and suggest areas of mitochondrial biology that are potential therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interaction of TLR9 with mtDNA activates the nuclear factor kappa B (NF-jB) signaling and increases the expression of other pro-inflammatory cytokines such as tumor necrosis factor-a (TNF-a), interleukin (IL)-6, IL-1b (Julian et al, 2013;Yu & Bennett, 2014;Zhang et al, 2014).”
From Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency (2018) · cites this paper as Yu & Bennett, 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Mitochondrial formation of reactive oxygen species
Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084 · cited 1×
“7 Mitochondrial DNA damage and atherosclerosis Mitochondria are the powerhouses of the cell, responsible for generating ATP through oxidative phosphorylation, with ROS formed as a by-product [8].”
BackgroundAMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602 · cited 1×
“AMPK activation has multiple effects, including inhibition of gluconeogenesis and adipogenesis [59] that could lead to reduced adiposity.”
BackgroundNLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026 · cited 2×
“Importantly NLRP3 inflammasome activation and increased IL1β release may promote atherosclerosis [52].”
BackgroundCirculating mitochondrial DAMPs cause inflammatory responses to injury
Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812 · cited 2×
“These inflammatory mtDNA motifs stimulate TLR9, leading to nuclear factor kappa beta (NFκβ) activation and transcription of inflammatory cytokines [45](Figure 3).”
BackgroundMitochondria: In Sickness and in Health
Nunnari, J., & Suomalainen, A. (2012) · Cell · doi:10.1016/j.cell.2012.02.035 · Cited by 3,479 · cited 1×
“We increasingly recognise that mtDNA defects not only impact upon mitochondrial and cellular function but whole organism metabolism [58] .”
BackgroundNakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
Geisler, S., Holmström, K. M., Skujat, D., Fiesel, F. C., Rothfuss, O. C., Kahle, P. J., & Springer, W. (2010) · Nature Cell Biology · doi:10.1038/ncb2012 · Cited by 2,835
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,651 · cited 1×
“Lipids, too, are a target of ROS and lipid oxidation is well-recognised as an important event in atherogenesis [22].”
Background
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–124 of 124
Liu, Y., Luo, N., Xi, X., Hou, J., Li, X., Xia, M., Yu, T., Yang, Y., & Liu, Y. (2026) · Drug Delivery · doi:10.1080/10717544.2026.2627689 · Cited by 6
“Fusion, mediated by mitofusins (Mfn1, Mfn2) on the outer membrane and optic atrophy 1 on the inner membrane, facilitates the merging of mitochondrial contents, enabling complementation of damaged components such as mitochondrial DNA (mtDNA) and proteins (Yu and Bennett 2014).”
Lorca, R., Aparicio, A., Gómez, J., Álvarez‐Velasco, R., Pascual, I., y, P. A., González-Urbistondo, F., Alén, A., Vázquez‐Coto, D., González-Fernández, M., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12062133 · Cited by 7
“Mitochondrial dysfunction can directly promote cell death, inflammation, oxidative stress, and alter metabolism [12].”
BackgroundInfluentialMerz, T., McCook, O., Denoix, N., Radermacher, P., Waller, C., & Kapapa, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179192 · Cited by 6
“Vascular comorbid patients are characterized by chronic hyper-inflammation, excess ROS formation, and mitochondrial dysfunction [31,32] and, accordingly, patients with underlying cardiovascular co-morbidity (hypertension, coronary artery disease (CAD), congestive heart failure) present with a several-fold higher risk…”
BackgroundBlevins, L. K., Khan, D. M. I. O., Crawford, R. B., O’Neill, C., Bach, A. P., Zhou, J., Karmaus, P. W. F., Ang, D. C., Thapa, R., & Kaminski, N. E. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2400193 · Cited by 5
Antisense molecules: A promising new therapy for atopic dermatitis
Xue, J., & Yao, Z. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.09.008 · Cited by 5
“Since the expression cassette-derived RNAi effectors are transcribed in the nucleus, they will not cross the endosomal compartment to activate TLRs 240 , but may still stimulate immunity via unmethylated CpG islands within the expression cassettes 241 .”
The Potential of Melatonin to Treat Atherosclerosis by Targeting Mitochondria
Sun, X., Chen, L., & Gui, Q. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230116102054 · Cited by 4
Biological Aging and Venous Thromboembolism: A Review of Telomeres and Beyond
Vostatek, R., & Ay, C. (2024) · Biomedicines · doi:10.3390/biomedicines13010015 · Cited by 5
Haykal, D., & Flament, F. (2026) · GeroScience · doi:10.1007/s11357-026-02331-7 · Cited by 2
Decoding vascular aging: implications for atherosclerosis progression and clinical intervention
Silumbwe, C. W., Ji, X., & Xu, M. (2024) · Exploration of Drug Science · doi:10.37349/eds.2024.00056 · Cited by 2
Subramaniyan, P., & Parthiban, V. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1750974 · Cited by 1
“Mitochondrial dysfunction has been associated with altered innate immune signaling, impaired resolution capacity, and sustained in fl ammatory tone, particularly through its in fl uence on pattern recognition receptor activation and downstream transcriptional programs (8 – 10).”
Gao, X., Pan, Y., Liu, Q., & Wu, H. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1748411 · Cited by 1
Influence of inflammation and mitochondrial mutations on cellular mechanisms of atherogenesis
Markin, A. M., Markina, Y. V., Tolstik, T. V., Bogatyreva, A. I., Sobenin, I. A., & Orekhov, A. N. (2020) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2020-9-4-80-87 · Cited by 1
“функции митохондрий подтверждает гипотезу накопления мутантных копий мтДНК в процессе атерогенеза [52].”
Metabolite toxicity and DNA damage in maple syrup urine disease
Lien, A. F. (2017) · BIBSYS Brage (BIBSYS (Norway)) · Cited by 1
Corrêa, R. (2016) · RIUnB Institutional Repository (University of Brasília) · doi:10.26512/2016.02.d.21081
Mitochondria and Cardiovascular Diseases
Prasun, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817006-9.00019-8
Yin, C., Wang, Y., Yang, H., Li, G.-S., Gao, Z.-C., Li, K.-Y., Zhou, G., Zhang, X., Xu, X.-Z., Tan, H., et al. (2025) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2024.12.009
Zhao, X., Yang, Y., Du, X., Li, L., Hou, C., Cai, Y., & Ma, X. (2025) · Experimental Biology and Medicine · doi:10.3389/ebm.2025.10624
“The initiation and progression of atherosclerosis are associated with cell death, oxidative metabolism, in fl ammatory cell activation state, and mitochondrial dysfunction [5 – 8].”
Mao, Y., Yang, X. J., & Hu, X. (2025) · PLoS ONE · doi:10.1371/journal.pone.0336139
van Hameren, G. (2018) · theses.fr (ABES) · doi:10.70675/71c15a42zb6d9z4edazb7c1zd3f51e09c949
Zhao, J., Duan, L., Li, J., Tian, C., Wang, G., Mi, J., Zhao, Y., Mu, J., Zhao, S., Han, M., et al. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119647
Plant-derived extracellular vesicles as emerging cardioprotective agents for cardiovascular diseases
Li, Q., Wang, Z., Huang, Q.-Y., Zheng, N., Zhai, B., Guo, D., Zou, J., Shi, Y., & Luan, F. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04765-9 · Cited by 2
“These pathological features make AS a suitable indication for evaluating whether PDEVs can regulate endothelial activation, macrophage lipid handling and plaque stability [170].”
Chen, Z., Yu, X., Tang, L., Zhao, Y., Yang, X. D., Su, R., & Xiong, Z. (2026) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001858
The Genetic and Epigenetic Mechanisms of mtDNA in Regulation of Inflammation and Metabolism
Zhang, Y., 郑言江, Duan, H., & Li, Y. (2026) · The FASEB Journal · doi:10.1096/fj.202600927r
Metadata
- Authors
- Yu, E. P. K., & Bennett, M. R.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- Yu, Emma P.K.
- Venue
- Trends in Endocrinology & Metabolism
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 25
- Issue
- 9
- Pages
- 481-487
- ISSN
- 1043-2760 (ISSN-L)
- OpenAlex
- W2047242190
- Cited by
- 124
- References
- 64
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 6 · 2023: 7 · 2022: 8 · 2021: 14 · 2020: 20 · 2019: 13 · 2018: 11 · 2017: 9 · 2016: 11 · 2015: 7 · 2014: 2
- FWCI
- 0.91
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Trends in Endocrinology and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (acceptedVersion, cc-by-nc-nd)
- Apollo (University of Cambridge) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- mitochondrial DNA damage, atherosclerosis, mitochondrial dysfunction, reactive oxygen species, oxidative stress, inflammation, cell death, metabolism, therapeutic target
- MeSH terms
- Animals, DNA Damage, DNA, Mitochondrial, Humans, Models, Biological, Apoptosis, Oxidative Stress, Atherosclerosis, Mitochondrial Dynamics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
